Skip to main content

Press

6th Biennial Pediatric Neuro-Oncology Research Conference
June 10-12, 2021

NOW VIRTUAL

REGISTRATION NOW OPEN

View Program  

 

Overview
The SNO 6th Biennial Pediatric Neuro-Oncology Research Conference is now virtual. Building on the success of our previous pediatric meetings, this biennial conference encourages the sharing of ideas and results, new collaborations, and offers attendees a state-of-the-art update in the field of pediatric brain tumor research. 

The scientific program will offer outstanding keynote and plenary addresses on a range of timely topics. Conference participants will also have opportunities to present their work and learn about other's advances — through short oral presentation and scientific posters selected by the abstract review committee. Against this backdrop, the conference promises to be an outstanding forum for networking and building lasting relationships with like-minded pediatric colleagues from around the world.

What's New This Year
This year's program will feature an Education Day on Saturday, June 12, with the theme "Defining Our Population." Participants will hear from expert speakers on topics such as health disparities, diversity and inclusion in clinical trials, AYA population, tumor predisposition syndromes, and BRAF mutations in adults and children.

Who Should Attend
Pediatric neuro-oncologists, medical oncologists, neurosurgeons, radiation oncologists, radiologists, physician/scientist, clinical and laboratory trainees, and allied health professionals.

What To Expect
  • Lectures, Q&A sessions, posters and poster discussions 
  • Live activities to earn AMA PRA Category  1 Credit and CME Certificate
  • Opportunities to engage with industry and nonprofit partners 
  • Accepted abstracts to be published in SNO's flagship journal Neuro-Oncology
  • Networking opportunities 
Learning Objectives
  • Describe best practices and strategies from US Cancer Centers of Excellence for incorporating a higher percentage of REMGs into their programs. 
  • Recognize new WHO classifications for pediatric CNS tumors and manage patient care accordingly. 
  • Indicate how to incorporate CAR T cell immunotherapy in pediatric patient treatment plans. 
  • Identify methods to better assess for and diagnose pediatric familial tumor predisposition.
  • Lectures, Q&A sessions, posters and poster discussions.
View current program.   

Scientific Program Co-Chairs
Stefan Pfister 

German Cancer Research Center
Heidelberg, Germany

Kathy Warren
Dana-Farber Cancer Institute
Boston, MA

Keynote Speaker
Pieter Wesseling
Amsterdam University Medical Centers
Amsterdam, The Netherlands Princess Máxima Center for Pediatric Oncology Utrecht, The Netherlands
Presentation topic:  Innovations in the New WHO Classification of CNS Tumors: How to Diagnose Brain Tumors in Children

Michelle Monje
Stanford University
Stanford, CA
Presentation topic: Developing CAR T-cell Immunotherapies for Children with CNS Tumors

Support Opportunities
This conference presents a unique opportunity to promote your organization to this highly specialized group of interdisciplinary professionals.  SNO is pleased to offer a variety of support opportunities with a range of price points to fit most any budget. For more information on how you can help move the needle in pediatric research and help improve children's outcomes, contact Megan Bell-Johnston.

Presenting Supporter